Herbert Irving Comprehensive Cancer Center
Investigator
Kevin Kalinsky, MD, MS
Email
kk2693@cumc.columbia.edu

Kevin Kalinsky, M.D., M.S. is an Assistant Professor of Medicine at the NewYork-Presbyterian Hospital/Columbia University Medical Center. Kalinsky received his undergraduate B.A. from Emory University. He received his M.D. from the Medical University of South Carolina and completed his Internal Medicine internship and residency and Hemathology/Oncology fellowship at Tufts Medical Center. In Boston, he also trained as a breast cancer clinical research fellow at Massachusetts General Hospital. In addition, he completed an advanced oncology fellowship in breast cancer at Memorial Sloan-Kettering Cancer Center. Since joining as a faculty member, Dr. Kalinsky completed a Master's program in Biostatistics, Patient-Oriented Research.

Dr. Kalinsky cares for patients diagnosed with breast cancer and teaches on the Breast Oncology service. Dr. Kalinsky's research involves the development of early phase clinical trials to assess novel therapeutic agents in breast cancer based on tumor genomics. The goal of his research is to translate findings developed at the bench to clinical trials for study at the bedside. His work is funded by a number of sources, including the National Institute of Health and SWOG/Hope Foundation.


Clinical Studies Managed By This Investigator:
Condition Study Title
Breast Cancer [ CLOSED ] A study for postmenopausal women with advanced or metastatic breast cancer using study drug MLN0128
Breast Cancer [ CLOSED ] Study for women with metastatic triple-negative breast cancer using study drug cobimetinib
Cancer [ CLOSED ] A study for patients with Epithelial Cancer using study drug IMMU-132
Breast Cancer [ CLOSED ] A study for patients with metastatic breast cancer using study drug Ricolinostat in combination with nab-paclitaxel
Breast Cancer [ CLOSED ] A study for women with breast cancer using a microfluidic device to detect leptomenigeal metastasis (LM)
Breast Cancer [ CLOSED ] A study for patients with LIV-1-positive metastatic breast cancer using study drug SGN-LIV1A
Breast Cancer [ CLOSED ] Study of Sacituzumab Govitecan in patients with triple-negative breast cancer
Breast Cancer [ CLOSED ] Optical Tomographic Imaging in Pre-Surgical Women with Breast Cancer
Breast Cancer [ CLOSED ] Study of Ruxolitinib in Combination with Trastuzumab in Metastatic HER2 Positive Breast Cancer
Breast Cancer [ CLOSED ] Pre-Surgical Trial of Sombination of Combination of Metformin and Atovastatin in Newly Diagnosed Operable Breast Cancer
Breast Cancer [ CLOSED ] Study of using patient's residual tumor to develop a cancer model
Breast Cancer [ CLOSED ] Study of Safety and Efficacy of Eribulin in Combination with Pembrolizumab in Breast Cancer Patients
Breast Cancer [ CLOSED ] Study of Escalating Doses of Study Drug in Patients with HER2 Positive Breast Cancer
Cancer [ CLOSED ] Study of Drug Combination in Subjects with Triple Negative Breast Cancer or Colorectal Cancer with Liver Metastases
Breast Cancer [ CLOSED ] Study of Combination Drug in Patients with Advanced Triple Negative Breast Cancer (TNBC)
Cancer [ CLOSED ] Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors